AngioSoma, Inc. ($SOAN, OTCQB) is a clinical stage biotechnology company improving the effectiveness of treatments related to endovascular interventions PAD.
Unnecessary #heart procedures can be avoided with a non-invasive test, according to late breaking research published in Journal of the American College of #Cardiology. #HeartNews
https://t.co/JJv9aepkbj
#Cosmeceuticals are the marriage of #cosmetics and #pharmaceuticals. They contain active ingredients that are known to be beneficial to humans in some way, like when vitamin C, a known #antioxidant , is added to a lotion or cream.
AngioSoma develops these beneficial products.
The #nutraceutical market has been making rapid strides in recent years. The growth is due to factors such as consumers’ focus toward #health & #wellness, a rapid growth in #obesity and other chronic lifestyle diseases, and a change in lifestyle and food preferences.
#Sleep is an essential part of keeping your #heart healthy. If you don’t sleep enough, you may be at a higher risk for #cardiovascular disease no matter your age or other health habits. Shoot for 7-8 hours per day. #HeartHealth
#Biotechnology has applications in four major industrial areas, including #health care (medical), crop production and agriculture, non-food (industrial) uses of crops and other products (e.g. biodegradable plastics, vegetable oil, biofuels), and environmental uses. #investing
#Biotechnology has changed traditional industries such as food processing and fermentation and given rise to a whole new technology for industrial production of #hormones, #antibiotics and other chemicals, food and #energy sources and processing of waste materials. #biotech